Optime Care
  • Home
  • About
  • Leadership
  • Stories
  • Careers
  • Contact
  • Home
  • About
  • Leadership
  • Stories
  • Careers
  • Contact
Rare Voices

The trusted path to optimal patient care.

Articles
October 16, 2020

9 Steps to Improving Patient Access to Rare and Orphan Drugs

A conversation on eHealth Radio Recently, I had the privilege of a thought-provoking conversation on…
Donovan Quill
0
Bill Jollie Podcast
September 24, 2020

Rare Voices S1E4: Bill Jollie, Global Pharmaceutical

https://soundcloud.com/rare-voices/s1e4-bill-jollie-global-pharmaceutical In healthcare, it is easy to become cynical. We are surrounded by the shortcomings…
Donovan Quill
0
Caring in the time of COVID Articles
September 22, 2020

How to Stay Focused on Rare and Orphan Disorders in the Time of COVID

4 Critical Success Factors for Manufacturers Before I became president and CEO of Optime Care,…
Donovan Quill
0
Donovan Quill
By Donovan Quill In News

Optime Care Featured in Onco’Zine — Created to Inform and Support Physicians & Healthcare Professionals Treating Cancer Patients

Read Article
Donovan Quill
By Donovan Quill In News

Optime Care Specialty Rx Pharmacists Employ Patient-First Strategy, Maximize Orphan and Rare Disease Management, Optimize Patient Journey and Outcomes

Read Article

I have a Rare Voice

Become a Guest
Donovan Quill
0
Products first means patients get left behind
Articles
August 20, 2020

Product First Means Patients Left Behind

A tale of too many patients. My family has a long history of alpha-1 antitrypsin…
Read More
Donovan Quill
0
scale vs. service
Articles
July 13, 2020

Scale vs. Service? Your rare drug demands both.

When developing a drug commercialization strategy, there’s a misconception that patient service and program scalability are mutually exclusive. The prevailing…
Read More
Donovan Quill
3
Ken Greathouse
Podcast
July 7, 2020

Rare Voices S1E3: Ken Greathouse, Valcrest Pharmaceuticals

Some people are the unique combination of visionary genius and thoughtful character. They connect the…
Read More
Donovan Quill
1
Jim Clement
Podcast
July 7, 2020

Rare Voices S1E2: Jim Clement, Coeus Consulting

One of the least understood components of commercialization is the role of the payer.  For…
Read More
Donovan Quill
1
Candace Lerman, Esq.
Podcast
July 7, 2020

Rare Voices S1E1: Candace Lerman, RareCandace.com

You never get a second chance to introduce your first episode. So, we wanted to start…
Read More
Donovan Quill
2
Rare Voices Podcast by Optime Care
Podcast
June 29, 2020

Introducing Rare Voices

Introducing Rare Voices The wise path to a fulfilled life for patients with rare and…
Read More
Michelle Hefley
1
hub and spoke model for rare and orphan drugs
Articles
June 18, 2020

Revealing 5 hidden truths about using a hub-and-spoke model for rare and orphan drugs

The hub-and-spoke approach has become a standard of drug commercialization. Having a network of patient…
Read More
Donovan Quill
1
gaining payer access for rare and orphan drugs
Articles
June 16, 2020

Debunking 6 Myths About Gaining Payer Access for Rare and Orphan Drugs

What works for large patient populations isn’t necessarily a good fit for those with rare…
Read More

Rare Voices Home

Categories

  • Articles (6)
  • News (6)
  • Podcast (5)

RSS Rare Voices Podcast

  • S1E4: Bill Jollie, Global Pharmaceutical September 24, 2020
  • S1E3: Ken Greathouse, serial entrepreneur and philanthropist July 7, 2020
  • S1E2: Jim Clement, Coues Consulting July 7, 2020

Listen to Rare Voices on:

Apple iTunes
Soundcloud
Stitcher
Spotify

Stay Informed

Optime Care Newsletter Signup

Privacy Policy
Orange County Web Design by Website Muscle
© 2020 Optime Care